Skip to main content

Advertisement

Table 1 Characteristics of patients

From: A phase II clinical trial to investigate the effect of pioglitazone on 18F-FDG uptake in malignant lesions

Characteristics
Age (mean ± SD, year) 64.0 ± 11.8    
Sex (M:F) 30:13     
Type of malignancy Responder (lesion/patient) Non-responder (lesion/patient) Benign lesion Responder (lesion/patient) Non-responder (lesion/patient)
Hepatobiliary and pancreatic cancer 18/9 6/4 Mediastinal lymph node 9/7 4/3
Hepatocellular carcinoma 7/6 5/4 Pneumonia 1/1
Colorectal cancer 7/5 2/1 Rib fracture 1/1
Gastric cancer 4/4 7/4 Liver cyst 1/1
Esophageal cancer 3/1 2/1    
Renal cell carcinoma 2/1    
Duodenal GIST 1/1    
Lung cancer 1/1